Aclaris Therapeutics

Public

Wayne, PennsylvaniaHealth Careaclaristx.com

Aclaris Therapeutics is now publicly traded

The data on this page reflects Aclaris Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Oct 6, 2015

Last Round

Private Placement

Nov 18, 2024

Est. Valuation at Exit

$295M

Total Funding Raised

$422.75M

Company Overview

Aclaris Therapeutics (NAS: ACRS) is a biopharmaceutical company focused on developing innovative drug candidates for immuno-inflammatory diseases while also providing laboratory services through its contract research segment.

Sector

Health Care

AI Layer

Non-AI

Keywords

immuno-inflammatory disease therapeuticsT cell-mediated autoimmune disease treatmentsatopic dermatitis drug candidatesselective JAK inhibitor developmentoral covalent ITK/JAK3 inhibitoranti-TSLP monoclonal antibodybiopharmaceutical drug licensingprotein kinase inhibitor discovery platformtopical soft JAK 1/3 inhibitorcontract research laboratory servicesMK2 inhibitor for cancerbispecific antibody for immunologic disease

Aclaris Therapeutics Comparables

Compare Aclaris Therapeutics with similar companies based on industry and business-model similarity.

Aclaris Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Aclaris Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Nov 18, 2024
Follow-on Offering	Jun 9, 2021
Debt	Mar 31, 2020
Follow-on Offering	Nov 17, 2016
IPO	Oct 6, 2015
Series B	Oct 2, 2014

View all Funding Rounds

Aclaris Therapeutics Investors

Notable investors and investment history

Aclaris Therapeutics investors
Investor	Rounds
Jefferies	IPO
RA Capital Management	Private Placement
Logos Capital	Private Placement
Forge Life Science Partners	Private Placement
Adage Capital Partners, L.P.	Private Placement
F-Prime Capital	Series B, Series A
William Blair & Company	IPO

View all Investors

Aclaris Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aclaris Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersWayne, Pennsylvania

Employee Range67

Year Founded2012

Last FundingNov 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.